Vaccines to prevent infectious diseases have saved millions of lives worldwide, yet there remains a need for new and improved vaccines against existing and emerging infections. Efforts to develop safe and effective preventative vaccines increasingly involve the use of adjuvants—substances formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvant discovery and development play critical roles in NIAID’s vaccine development efforts.
NIH Begins Testing H7N9 Avian Influenza Vaccine Candidate: Possible Role For Adjuvants to Be Examined—Sept. 18, 2013
Novel Approach for Influenza Vaccination Shows Promise in Early Animal Testing: New Research Advances Development of Universal Flu Vaccine—May 22, 2013
Test Vaccine Successfully Protects Monkeys from Nipah Virus—Aug. 8, 2012
All Vaccine Research News Releases
News From NIAID-Supported Institutions
Last Updated May 13, 2014
Last Reviewed May 13, 2014